Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional CO2 laser + bimatoprost + NB-UVB versus fractional CO2 laser + NB-UVB in non-segmental vitiligo
TCTR20200923001Phase 2Not yet recruiting
- Sponsor
- Srinakharinwirot University
- Start
- Nov 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of bimatoprost in Vitiligo (2 arms), sponsored by Srinakharinwirot University. Planned start Nov 2020; status: not yet recruiting.
02
Drugs
bimatoprost
03
Conditions
Vitiligo
Beyond the preview
Go deeper on TCTR20200923001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200923001.